# Deep Fungal Stromal Keratitis After Cataract Surgery: A Case Report

**Authors:** Seika Narai, Atsuhiko Fukuto, Tai-ichiro Chikama, Yosuke Harada, Hirokazu Sakaguchi

PMC · DOI: 10.7759/cureus.83101 · Cureus · 2025-04-27

## TL;DR

A rare case of deep fungal eye infection after cataract surgery was successfully treated with amphotericin B after other antifungal treatments failed.

## Contribution

Highlights the diagnostic role of in vivo confocal microscopy and treatment success with amphotericin B in deep stromal fungal keratitis.

## Key findings

- In vivo confocal microscopy identified filamentous structures in deep stromal fungal keratitis.
- Amphotericin B via multiple routes resolved the infection when other treatments failed.
- Therapeutic keratoplasty was avoided through effective antifungal treatment.

## Abstract

Fungal keratitis is a vision-threatening infection that typically originates at the ocular surface and gradually invades the deeper layers of the cornea. We report a rare fungal keratitis confined to the deep stromal layer that developed following cataract surgery. An 81-year-old woman presented with a creeping white opacity on the posterior corneal surface in the right eye. Anterior segment optical coherence tomography revealed a hyper-reflective lesion at the posterior cornea, and in vivo confocal microscopy showed filamentous structures in the deep stroma, supporting the diagnosis of fungal keratitis. Corneal scraping was not feasible because the lesion was deep within the cornea. Initial treatment with natamycin and fluconazole was ineffective, and the infection progressed despite topical and systemic voriconazole. Ultimately, the infection resolved after administering amphotericin B via topical, intrastromal, and intravenous routes. The patient’s condition improved without requiring therapeutic keratoplasty. This case illustrates the diagnostic value of in vivo confocal microscopy in deep stromal fungal keratitis. It emphasizes the importance of selecting appropriate antifungal agents when first-line treatments are ineffective.

## Linked entities

- **Chemicals:** natamycin (PubChem CID 5284447), fluconazole (PubChem CID 3365), voriconazole (PubChem CID 71616), amphotericin B (PubChem CID 1972)
- **Diseases:** fungal keratitis (MONDO:0033821)

## Full-text entities

- **Diseases:** infection (MESH:D007239), Cataract (MESH:D002386), Fungal keratitis (MESH:D009181), Keratitis (MESH:D007634)
- **Chemicals:** fluconazole (MESH:D015725), voriconazole (MESH:D065819), natamycin (MESH:D010866), amphotericin B (MESH:D000666)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12117250/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12117250/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12117250/full.md

---
Source: https://tomesphere.com/paper/PMC12117250